feed,title,long_url,short_url
BioRxiv,Probing the SAM Binding Site of SARS-CoV-2 nsp14 in vitro Using SAM Competitive Inhibitors Guides Developing Selective bi-substrate Inhibitors,https://biorxiv.org/cgi/content/short/2021.02.19.424337v1?rss=1,https://j.mp/3qDQGmG
BioRxiv,Delivery of recombinant SARS-CoV-2 envelope protein into human cells,https://biorxiv.org/cgi/content/short/2021.02.18.431684v1?rss=1,https://j.mp/3k7zBz1
BioRxiv,Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay,https://biorxiv.org/cgi/content/short/2021.02.19.431973v1?rss=1,https://j.mp/2OUCoA6
BioRxiv,SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts,https://biorxiv.org/cgi/content/short/2021.02.19.431311v1?rss=1,https://j.mp/3bk28gU
BioRxiv,Antiviral activity of influenza A virus defective interfering particles against SARS-CoV-2 replication in vitro through stimulation of innate immunity,https://biorxiv.org/cgi/content/short/2021.02.19.431972v1?rss=1,https://j.mp/3pBL76T
